Omid Hamid MD
@omidhamidmd
Chief of Research and Immunotherapy • ImmunoOncology • Phase I Clinical Trials • Melanoma • Cutaneous Oncology
ID: 2171269956
http://www.theangelesclinic.org 03-11-2013 01:41:24
4,4K Tweet
4,4K Takipçi
810 Takip Edilen
New #JITC article: Long-term survival follow-up for tebentafusp in previously treated metastatic uveal melanoma bit.ly/3VHeckN Richard D Carvajal Omid Hamid MD Marcus Butler Alex Shoushtari, MD Jason Luke, MD, FACP
Did you see this data Paolo A. Ascierto presents @BMS Realtivity048 ASCO PD-1/LAG3/CTLA4 with OS curve !! Once again melanoma pushes the boundaries.... currently accruing this regimen +/-sarilumab #ASCO24 The Angeles Clinic NYU Langone Health MassGeneral Medicine Dana-Farber ascopubs.org/doi/10.1200/JC…
Listen to Omid Hamid MD, he's got the West Coast covered but Perlmutter Cancer Center at NYU Langone Health has this regimen +/sarilumab as a toxicity modulatory in New York City. State of the art regimen, but we are trying to improve it by making it less toxic. Our patients deserve no less.
Proud to have contributed through our Phase 1 program The Angeles Clinic to ensure immunotherapy’s role in all solid tumors. #worktodo
Appreciate ASCO The ASCO Post allowing me to discuss the future with Bispecific ImmTAC Immunocore #ASCO24 work done at many institutes including Cedars-Sinai The Angeles Clinic #Brenetefusp currently enrolling phase 3 trial for cutaneous #melanoma #ASCO24 ascopost.com/videos/2024-as…
In this episode of Targeted Talks, Omid Hamid, MD, (Omid Hamid MD) delves into the mechanism of action, supporting data, and approval of lifileucel for the treatment of advanced #melanoma. #MELSM | The Angeles Clinic targetedonc.com/view/advancing…
We’ve been cheering on Sydney McLaughlin-Levrone as she competes in the Summer Olympics, and last week, she brought home the gold in the 400m hurdles! Sydney is not only a champion on the track but also a powerful advocate for skin protection. Partnering with Neutrogena, our National Prevention
Listen to your friends, your family, your doctor, and a gold medal Olympian. Sydney McLaughlin-Levrone. We continue to fight to stop melanoma and search for cures but the best option is prevention The Angeles Clinic #worktodo
So sad to hear about the passing of Jeff Weber, a giant in the field of oncology. He was involved in the early days of cytokine and cell therapy and most recently led studies of personalized vaccines for melanoma patients. I originally worked with Jeff National Cancer Institute over 30 years ago.
🎉 🎉 Excited to share our latest research, now in Nature Cancer IrAEs can be associated with significant morbidity or mortality - our study suggests that targeting IL-17A CD4+ T cells could help manage these side effects better, and paves the way for 🎯 treatment approaches
Honored to be appointed Director of Experimental Therapeutics Cancer at Cedars-Sinai . Continuing work at The Angeles Clinic and Cedars-Sinai to bridge #phaseone #clinicaltrials to all patients. Justin Moyers Navid Hafez #clinicaltrialssavelives